A comparison of the presentation of patients with cervicogenic headaches and patients with non-cervicogenic headaches by Pramod, Abraham
A COMPARISON OF THE PRESENTATION OF PATIENTS 
WITH CERVICOGENIC HEADACHES AND PATIENTS 
WITH NON-CERVICOGENIC HEADACHES 
 
 
 
 
 
Abraham Pramod 
 
 
 
 
A research report submitted to the Faculty of Health Sciences, University of the 
Witwatersrand, Johannesburg in partial fulfilment of the requirements for the degree of 
Master of Science in Physiotherapy. 
Johannesburg 
2013 
 Page i 
 
DECLARATION 
 
I, Abraham Pramod declare that this research report is my own unaided work, except to the 
extent indicated in the reference citations and acknowledgements. It is being submitted for 
the degree of Master of Science in Physiotherapy at the University of the Witwatersrand, 
Johannesburg. It has not being submitted before for any other degree or examination at this or 
any other University. 
 
 
 
 
Date:……14th…….day of ……February…….2014 
 
 
 
 
 Page ii 
 
ACKNOWLEDGEMENTS 
I would like to thank my supervisors Benita Olivier and Douglas Maleka for their on-going 
guidance and support.  A special thanks to my wife Indu and children Tina and Anna for the 
family support during the time of my study. Last but not least, to my fellow physiotherapist 
Nonto and to all the participants in the study who made themselves available, thank you 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Page iii 
 
ABSTRACT 
Introduction: 
 Headache is one of the most common disorders of the nervous system and several of its 
subtypes lead to substantial levels of disability. Cervicogenic headache is a condition 
characterised by chronic hemi-cranial pain that is referred to the head from either bony 
structures or soft tissues of the neck. One of the common factors associated with all forms of 
headaches is the presence of trigger points. The aim of this study was to compare the 
sensitivity of trigger points, descriptive characteristics and level of disability in patients with 
cervicogenic and in patients with non-cervicogenic headaches.  
Methodology:   
The study was conducted as a quantitative, cross sectional, descriptive study. Forty 
participants (20 with cervicogenic and 20 non-cervicogenic headache) were included into this 
study sample. The classification of patients as having cervicogenic or non-cervicogenic 
headache was done according to the guidelines of Zito et al (2006). The sensitivity of trigger 
points in the upper trapezius, sternocleidomastoid, posterior cervical and temporalis muscles 
were established using a hand-held digital algometer with 1cm
2
 round head. Their level of 
disability was compared using the Henry Ford Headache Disability Inventory (HDI). The 
demographic and clinical presentation of both the groups was also compared including age, 
sex, duration of headache and pain rate scale. The above mentioned variables were compared 
using student t-test and chi-square test. 
Results:  
 Descriptive characteristics, pain intensity and level of disability did not attain a statistical 
significant difference between the two groups. The results found evidence of a statistically 
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significant difference with respect to trigger points sensitivity in right upper trapezius 
(p=0.02) and left upper trapezius (p=0.01). The sensitivity of trigger points of upper trapezius 
were higher in cervicogenic groups but none of the other muscles tested showed difference in 
sensitivity between both groups. 
Discussion 
Similarities in the descriptive characteristics, pain intensity and level of disability of both 
groups suggest that both types of headaches cannot be differentiated in terms of a specific 
age, sex, body mass index, pain intensity or level of disability. Increased sensitivity of trigger 
points especially in upper trapezius may be used as an additional diagnosing factor of 
cervicogenic headache group. 
 Conclusion:  
The results of this study found that patients with cervicogenic headache had an increased 
sensitivity of the upper trapezius muscles compared to patients with non-cervicogenic 
headache. Since physiotherapists play an important role in the treatment of trigger points the 
value of physiotherapy treatment in the management of cervicogenic headache releasing the 
trigger points in the upper trapezius may result in a decrease in symptoms and an associated 
improvement in quality of life. 
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LIST OF ABBREVIATIONS 
SCM- Sternocleidomastoid 
BMI- Body Mass Index 
CTTH- Chronic tension type headache 
TrPs- Trigger points 
ADL- Activities of Daily Living  
HDI- Headache Disability Inventory 
IHS- International Headache Society  
NPRS- Numeric Pain Rating Scale 
VAS- Visual Analogue Scale 
ROM- Range of Movement 
 
 
 
 
 
 
 
 Page vi 
 
TABLE OF CONTENTS        Pg                                                                                                                             
Declaration           i 
Acknowledgements          ii 
Abstract           iii 
List of abbreviations          v 
Table of contents          vi 
List of appendix          x 
List of tables           x 
List of figures           xi 
1. CHAPTER 1:        
1.0: Introduction          1 
1.1: Background          1 
1.2: Problem statement         2 
1.3: Research question         3 
1.4: Aim           3 
1.5: Objectives          3 
1.6: Significance          4 
 Page vii 
 
2. CHAPTER 2:  
2.0: Literature review              5 
2.1: Introduction              5 
2.2: Classification of headaches            5 
2.3: Cervicogenic headache             6 
2.4: Patho-physiology of cervicogenic headache          7 
2.5: Diagnostic Criteria             8 
2.6: Trigger points            11 
2.7: Physiotherapy treatment of trigger points        15 
2.8: Measurement Instruments                                           16 
2.8.1: Assessing trigger points using algometer                                                                       15             
2.8.2: Assessing pain using numeric pain rating scale                                                             17 
2.8.3: Assessing disability using The Henry Ford headache disability inventory               19 
2.9:  Physiotherapy management for cervicogenic headache       20 
2.10: Summary            21 
3. CHAPTER 3:            22 
3.0: Methodology            22 
3.1: Study design                         22 
3.2: Pilot Study            22 
 Page viii 
 
3.2.1: Introduction                                                                                                                    22 
3.2.2: Procedure for the pilot study          23                      
3.2.3: Results of the pilot and recommendations for the main study      23                                                                                               
3.3: Main study            24 
3.3.1: Participants           24               
3.3.1.1: Inclusion criteria                                                                                             24 
3.3.1.2: Exclusion criteria                                                                                            24 
            3.3.1.3: Participant recruitment and setting                   23                
3.3.2: Sample size           24 
3.3.3: Instrumentation and outcome measures       25 
3.3.3.1: Details of the algometer                              26 
           3.3.3.2: The Henry Ford Hospital Headache Disability Inventory    26 
3.3:4: Procedure protocol          27 
3.4: Data analysis            28 
3.5 Ethical considerations                                                                                                        29 
4.  CHAPTER 4:            30                             
4.0: Results             30 
4.1: Descriptive characteristics of the study population     30 
 
 Page ix 
 
 
4.2: Presence of Trigger points and sensitivity comparison between cervicogenic and  
        non-cervicogenic headaches                                                                                            30    
4.3: A comparison of the cervicogenic and non-cervicogenic groups in terms  
        of self-perceived disability    31                  
4.4:  Conclusion           36 
5. Chapter 5:            37 
5.0: Discussion           37 
5.1: Demographic data                                                                                                             37       34 
5.2: Trigger point sensitivity comparison between cervicogenic and  
        non-cervicogenic headaches                                                                                            38 
5.3: A comparison of the cervicogenic and non-cervicogenic groups  
       in terms of self-perceived disability        40 
5.4: Conclusion           41 
6.  CHAPTER 6:           42 
6.0: Conclusion           42 
6.1: Study limitations            42 
6.2: Clinical recommendations          42 
6.3: Recommendations for future research         43       
REFERENCES            44 
 
 Page x 
 
 
List of Appendices 
Appendix i: Diagnosis of cervicogenic headaches       49 
 Appendix ii: Ethics committee clearance certificate       51 
Appendix iii: Informed consent form                               52 
Appendix iv: Information sheet to referring medical practitioners        53 
Appendix v:  Information sheet to participants                                                56 
Appendix vi: Algometer report                                                     59 
Appendix vii: Headache disability index questionnaire                                       60 
Appendix viii: Demographic questionnaire        61 
Appendix ix: Numeric pain rating scale                   62 
Appendix x: Faculty clearance letter                    63 
 
LIST OF TABLES 
Table 2.1: Theories of pathogenesis for Cervicogenic headache        8 
Table 4.1: Demographic representation of the cervicogenic and 
                   non-cervicogenic groups                                                                             30                                                                                                                                                                      
Table 4.2: Descriptive characteristics of the cervicogenic and non-cervicogenic groups       30                                  
Table 4.3: Trigger point sensitivity in cervicogenic and non-cervicogenic groups                 31 
 Page xi 
 
Table 4.4: Total functional and emotional score and pain rate scale of both groups  32 
Table 4.5:  A Comparison of the Cervicogenic and Non-Cervicogenic participants 
using the Henry Ford Headache Disability Inventory (HDI) (emotional 
items) 33 
Table 4.6:  A Comparison of the Cervicogenic and Non-Cervicogenic participants 
using (HDI) (functional items) 34 
  
LIST OF FIGURES 
Figure 1: Referred pain patterns of Trigger points      14 
Figure 2: Sub occipital region pressure gauge algometer application   17 
 
 
 P a g e  | 1 
 
CHAPTER 1 
1.0  INTRODUCTION 
The background for this study will be explained in this chapter including the problem 
statement, the main aims, research question, objectives and significance of the study.  
 
1.1  Background 
Headache is one of the most common disorders of the nervous system and several of its 
subtypes lead to substantial levels of disability (Stovner et al 2007). It is a common complaint 
in society and is often related to personal, biomechanical and socioeconomic circumstances 
(Jull and Sterling 2008). Cervicogenic headache is a condition characterised by chronic hemi-
cranial pain that is referred to the head from either bony structures or soft tissues of the neck 
and can be provoked by neck movements (Biondi 2005). It is mostly unilateral (Biondi 2005) 
but can also present bilateral (Sjaastad and Faffenrath 1998). In addition, this type of 
headache is thought to have a marked female preponderance, occurring after whiplash 
trauma, and to be associated with a reduction of range of neck movements and with ipsilateral 
shoulder and arm pain (Fishbain et al 2003). A detailed criterion has been explained by 
Sjaastad and Faffenrath (1998) for the diagnosis of cervicogenic headache which is based 
mainly on the history, temporal pattern and aggravating factors of the headache. Zito et al 
(2006) developed manual examination criterion which is considered to be simple, 
conservative and inexpensive in diagnosing cervicogenic headaches. 
 
One of the common factors associated with all forms of headaches is the presence of trigger 
points (TrPs) (Fernandez-de-las-Penas et al 2006 and Simons 2002). A myofascial trigger 
point (TrPs) is a hyperirritable spot associated with a taut band of a skeletal muscle that is 
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painful on compression or stretch, and that can give rise to a typical referred pain pattern as 
well as autonomic phenomena (Simons 2002). The formation of these TrPs may result from a 
variety of factors such as trauma, overuse, physical and psychological stress and joint 
dysfunction. Usually there is a taut band in muscles containing TrPs and a hard nodule can be 
felt. Pressing on the affected muscle can often refer pain in a distant reference zone. Trigger 
points are classified as either active (which causes the patient pain) or latent (tender although 
not much pain but causes restriction of movement and weakness of the affected muscles). 
 
Trigger points associated with headaches are mainly present in upper trapezius, 
sternocleidomastoid (SCM), posterior cervical muscles and temporalis (Simons 2002). 
Scientific studies strongly suggest that there are myofascial TrPs points present in the cranial 
& peri-cranial muscles that refer pain to the head which might have a considerable role in 
influencing the symptoms of headache (Fernandez-de-las-Penas et al 2006). Trigger points 
should be considered as a possible factor of trigger of pain in many forms of headaches 
(Davidoff 1998). Myofascial TrPs are found in most of the patients with cervicogenic as well 
as in patients with non cervicogenic headaches (Bovim 1992). Fishbain et al (2003) reported 
patients with cervicogenic headache have a greater number of TrPs on the symptomatic side 
of the neck versus the other side; also patients with cervicogenic headache have been noted to 
have lower pressure-pain threshold measurements in the neck versus patients with migraine 
and tension headache.  
 
1.2  Problem statement 
A critical review of the literature has shown an ample number of studies on myofascial TrPs, 
cervicogenic headaches and physiotherapy treatment of TrPs (Issa & Huijbregts, 2006). 
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There is however a need for literature on the sensitivity of the trigger points and the 
comparison of presentation between the cervicogenic and non-cervicogenic headache groups. 
 
1.3 Research question 
Is there a difference in presentation of patients with cervicogenic headaches and patients with 
non-cervicogenic headaches? 
 
1.4 Aim 
The aim of the study is to compare the presentation of patients with cervicogenic headaches 
and patients with non-cervicogenic headaches. 
 
1.5 The objectives of this study were to: 
1. Determine the descriptive characteristics (using a demographic questionnaire) and level of 
disability [using the Headache Disability Index questionnaire (HDI)] in patients with 
cervicogenic headaches and in patients with non-cervicogenic headaches. 
2. Determine the presence and sensitivity of trigger points in various muscles of the neck of 
patients with cervicogenic headaches and in patients with non-cervicogenic headaches. 
3. Compare the presence and sensitivity of TrPs as well as the descriptive characteristics and; 
level of disability between patients with cervicogenic headaches and patients with non-
cervicogenic headaches. 
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1.6  Significance 
If the difference or similarity in presentation of patients with cervicogenic and non-
cervicogenic headaches can be established, appropriate recommendations can be made with 
regards to the physiotherapy treatment. If painful TrPs can be found consistently and 
repeatedly in cervicogenic headache patients, then measurement of change in their tenderness 
level may be useful as a physical outcome measure (Roth et al 2007). Physiotherapy is one of 
the treatment regimens indicated for patients suffering from chronic headaches. The treatment 
regime includes orthopaedic manipulative therapy, patient education, stretching exercises and 
releasing the TrPs points in the muscles (Issa and Huijbregts 2006).  Fernandez-de-las-Penas 
et al (2008) reported the improvement as a result of trigger point therapy for patients with 
chronic tension type headaches. The presence of TrPs is associated with cervicogenic 
headache (Roth et al 2007) but has also been associated with other types of headache 
(Davidoff 1998). The aim of the physiotherapy treatment is to reduce pain and reinstate 
normal function by deactivation of the trigger points. The results from this study may also 
lead to future research on the contribution of TrPs in pain experienced by patients suffering 
from cervicogenic and non cervicogenic headaches. Furthermore, this study may add to the 
current evidence in presentation of cervicogenic and non-cervicogenic groups and also 
increase the awareness amongst physiotherapists treating individuals suffering from 
headaches. 
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CHAPTER 2 
2.0  LITERATURE  REVIEW 
 
2.1  Introduction 
The literature related to this study will be discussed in this chapter. The classification of 
headaches, pathology, diagnosis and characteristic features of cervicogenic headaches, trigger 
points and their role in headache patients and the role of physiotherapy in treating patients 
with cervicogenic headaches are mentioned in this chapter. A brief overview of the 
algometer, Numeric Pain Rating Scale and HDI is also mentioned.  The databases searched 
include: MEDLINE via PubMed, Cumulative Index to Nursing and Allied Health Literature 
(CINAHL), the Cochrane Controlled Trials Register in the Cochrane Library, Physiotherapy 
Evidence Database (PEDro), ProQuest 5000 International, ProQuest Health and Medical 
Complete, EBSCO MegaFile Premier, Science Direct and SCOPUS. The search for 
unpublished studies will include: EBSCO MegaFile Premier. The key words that were used 
were “cervicogenic and non-cervicogenic  headaches, algometer, trigger points, headache 
disability index and pain rate scale”. 
 
2.2 Classification of headaches 
According to The International Headache Society (2004), fourteen different types and sub 
classifications of headaches have being identified. There are two basic categories of 
headaches, namely primary and secondary headaches. Primary headaches include those of 
vascular origin (cluster and migraine headaches) as well as those of muscular origin (tension-
type headaches). Secondary headaches result from another source including inflammation or 
head and neck injuries. Norwegian physician Dr.Ottar Sjaastad coined the term, 
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“cervicogenic headache” in 1983 by recognizing a sub-group of headache patients with 
concomitant head and neck pain; therefore, cervicogenic headaches are considered 
“secondary headaches” (Sjaastad  et al  1983). 
 
2.3  Cervicogenic headache 
Cervicogenic headache  is a type of secondary headache characterised by unilateral headache 
and symptoms and signs of neck involvement (Chaibi and Russell 2012) and is often 
worsened by neck movement, sustained awkward head position or external pressure over the 
upper cervical or occipital region on the symptomatic side (Knackstedt et al 2010). It 
accounts for 15–20% of all headaches and it is sometimes related to the abnormal activity of 
motor units in neck and shoulder girdle muscles (Huber et al 2012). This represents a 
heterogeneous group of disorders that commonly refer pain from structures in the cervical 
spine region (e.g. joints, muscle, and nerve) to various regions in the head (Roth et al 2007). 
Major features are unilateral pain that typically starts at the occipital-nuchal area and spreads 
to the ipsilateral forehead, and attack induction by neck movements and/or digital pressure 
over trigger points such as the greater occipital nerve or the C2 area. Additionally, there may 
be diffuse, vague ipsilateral arm pain or discomfort (Vincent and Lun 1997).  Mean age range 
at onset has been reported as 33-43years, and mean duration of symptoms of 7-17yrs. Patients 
with cervicogenic headaches have a substantial quality of life burden (Hall et al 2008 & Van 
Svijlekom et al 2003) and demonstrate the greatest loss in domains of physical functioning 
compared to patients with migraine and tension-type headache (Hong et al  2010). 
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2.4  Pathophysiology of cervicogenic headache 
One of the most controversial areas within the cervicogenic headache literature is the 
discussion of its cause, with almost every structure and pathology within the cervical spine 
been implicated as a cause of these headaches (Haldeman and Degenais 2001). Structures 
implicated in the genesis of cervicogenic headaches all have their sensory innervations 
through the upper cervical and mid-cervical nerve roots, which lead to the cervical cord and 
converge within the spinal tract of the trigeminal nucleus allowing for nociceptive input from 
cervical structures to be perceived as head pain, including pain to the temporal, frontal, and 
orbital regions. This convergence may also help to explain the systemic and sympathetic 
nervous system features accompanying cervicogenic headaches (Haldeman and Degenais 
2001).  
One theory of cervicogenic headache aetiology comes from anatomical studies showing an 
attachment of the sub-occipital tissues to the dura mater at the cervical–cranial junction, and 
the observation that mechanical traction on these tissues can cause movement of the dura 
mater (Haldeman and Degenais 2001). The rectus capitus posterior minor muscle and 
ligamentum nuchae have been shown to have direct connections to the sub-occipital dura on 
very delicate dissection in a small number of cadavers. This suggests a role for the dura as a 
nociceptive structure in cervicogenic headache (Alix and Bates 1999). Martelletti (2000) 
reported increased levels of pro-inflammatory cytokines interleukin-Iß and tumour necrosis 
factor-α during mechanically induced attacks of cervicogenic headache defining cervicogenic 
headache as an inflammatory consequence of cervical trauma, explaining the wide variety of 
pathological processes in different structures that can cause similar headaches. He postulated 
that this could represent a specific signal from the immune system to activate nociceptive 
inducing agents as substance P and calcitonin-gene–related peptide. The table below shows 
  
 P a g e  | 8 
  
the various theories for the pathology of cervicogenic headache (Haldeman and Degenais 
2001). 
TABLE 2.1 Theories of pathogenesis for cervicogenic headache 
  
 
An accurate diagnosis of the aetiology of cervicogenic headache can be challenging for the 
clinician due to the overlap of pain (in the neck and head) and associated symptoms between 
cervicogenic headache and primary headache and the multiple abnormalities of the cervical 
spine and musculature that can be a primary source of head pain (Roth et al 2007). 
 
2.5  Diagnostic Criteria 
The diagnosis of cervicogenic headache can be a significant clinical challenge. The first 
attempt at setting forth diagnostic criteria for cervicogenic headache was made in 1990 
(Sjaastad and Faffenrath 1998). Although the publication of these criteria brought focus to the 
field of cervicogenic headache research, certain aspects have proved difficult to embrace; 
Structure Pathology Mechanism 
Zygapophysial or 
facet joint 
Irritation, 
Rheumatoid arthritis 
Trauma or immobility stimulates the C1–C3 
nerves 
Cervical muscles Myofacial trigger 
points, myo-spasm 
Restrict joint motion. Referred symptoms 
from muscles innervated by C1–C3 
Intervertebral disc Trauma 
Herniation 
Irritates the dura 
Stimulates sinuvertebral nerve 
Nerve roots Compression 
Irritation 
Disk herniation, spondylosis, or scar tissue  
 
Vertebral artery Compress Apophyseal exostoses impacting vertebral 
artery blood flow 
Uncovertebral 
joints 
Mechanical irritation Nerve roots producing sternocleidomastoid 
and trapezius muscle spasm 
Ponticus posterior Articular lock, 
instability 
Tension on the dura or vertebrobasilar artery 
compression 
Rectus capitis 
muscle 
Connective tissue 
bridge with the dura 
Tension on the dura 
Ligamentum 
nuchae 
Attaches to the dura Tension on the dura 
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these include the position that these headaches should be strictly unilateral, the inclusion of a 
number of accompanying symptoms, such as nausea, vomiting, flushing, dizziness, phono- 
and photophobia, blurred vision, and dysphagia. This made the criteria too specific and 
detailed for general practice ( Dagenais & Haldeman 2001). This highlighted the need for 
clear criterion of cervical musculoskeletal impairment to identify cervicogenic headache 
sufferers.  In addition, it appears that migraine headache demonstrate neck-associated 
symptoms such as occipital neck tenderness and trigger points  thought  to be characteristic of 
cervicogenic headache, making the differentiation of migraine headache from cervicogenic 
headache  problematic (Fishbain et al 2003).  According to the second edition of the 
International Classification of Headache Disorders [IHS (2004)], the diagnostic criteria are 
based on the following: 
A. Pain, referred from a source in the neck and perceived in one or more regions 
of the head and/or face, fulfilling criteria C and D. 
B. Clinical, laboratory, and/or imaging evidence of a disorder or lesion within the 
cervical spine or soft tissues of the neck known to be, or generally accepted as, 
a valid cause of headache. 
C. Evidence that the pain can be attributed to the neck disorder or lesion based on 
at least one of the following: 
1. Demonstration of the clinical signs that implicate a source of pain in 
the neck 
2. Abolition of headache following diagnostic blockade of a cervical 
structure or its nerve supply using placebo or other adequate controls 
D. Pain resolves within three months after successful treatment of causative 
disorder or lesion. 
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Zito et al (2006) in accordance with International Headache Society IHS (2004) was able to 
identify musculoskeletal criteria identifying physical impairments in the musculoskeletal 
system linked to clinical features will contribute to the justification and selection of treatment 
for cervicogenic headache. Zito et al (2006) manual examination criterion for identifying 
cervicogenic headache patients consists of: 
a) measurement of cervical flexion and extension, will be decreased in cervicogenic 
group (according to Knackstedt et al 2010 decreased  at least by 20 degrees in 
cervicogenic group ) 
b) manual assessment of O/C1, C1/C2,C2/C3 (painful segmental dysfunction in 
cervicogenic group) 
c) muscle extensibility- Upper trapezius, Scalenes, Levator Scapulae, Short Cervical 
extensors, Pectoralis major & minor ( muscle tightness higher in cervicogenic group) 
The clinical characteristics explained by Biondi (2005) for cervicogenic headache patients 
are: 
1. Unilateral head or face pain without side shift; the pain may occasionally be bilateral 
2.  Pain localised to the occipital, frontal, temporal or orbital regions 
3. Moderate to severe pain intensity 
4. Intermittent attacks of pain lasting hours to days, constant pain or constant pain with 
superimposed attacks of pain 
5.  Pain is generally deep and non-throbbing; throbbing may occur when migraine 
attacks are superimposed 
6. Head pain is triggered by neck movement, sustained or awkward neck postures; 
digital pressure to the sub occipital, C2, C3, or C4 regions or over the greater occipital 
nerve; valsalva cough or sneeze might also trigger pain 
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7. Restricted active and passive neck range of motion; neck stiffness 
8. Associated signs and symptoms can be similar to typical migraine accompaniments 
including nausea, vomiting, photophobia, phonophobia and dizziness. 
More recently, Antonaci and Sjaastad (2011) reported that unilateral headache of 
posterior onset, which eventually spreads to the forehead was a free variable, but proved 
to be almost invariably present and for that reason should probably be included among the 
regular cervicogenic headache criteria. Zito et al (2006) manual examination criterion is 
considered to be simple, conservative and inexpensive in diagnosing cervicogenic 
headaches. 
 
2.6  Trigger points 
A myofascial trigger point (TrPs) is a hyperirritable spot associated with a taut band of a 
skeletal muscle that is painful on compression or stretch, and that can give rise to a typical 
referred pain pattern as well as autonomic phenomena (Simons and Travell 1999). The point 
is a well-circumscribed area in which pressure produces a characteristic referred pain, 
tenderness and autonomic phenomena (Bablis et al 2008). TrPs are considered an essential 
defining part of the myofascial pain syndrome, in which widespread or regional muscular 
pain is a cause of musculoskeletal dysfunction as well as being associated with hyperalgesia, 
restriction of daily function or psychological disturbance (Bablis et al 2008). The 
pathogenesis of TrPs is not well understood, but it is believed they arise from more than one 
cause and formation may result from a variety of factors such as trauma, overuse, overstress, 
psychological stress and joint dysfunction where a hard nodule can usually be felt in a taut 
band in muscles containing the trigger point (Fernandez-de-las-Penas et al 2006 and Bablis et 
al 2008). Often a twitch response can be felt in the muscle by running your finger 
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perpendicular to the muscles direction. Pressing on the affected muscle can often refer pain in 
a distant reference zone. Muscle tightness and triggerpoints associated with cervicogenic 
patients are predominently found in upper trapezius, sternocliedomastoid (SCM), scalenes, 
levator scapule, pectoralis major and minor and short sub-occipital extensors (Hall et al 2008 
and Page 2011). Upon clinical examination, TrPs are of two major types; an active trigger 
point is defined as one with spontaneous pain, or pain in response to movement, it is tender 
on palpation, and may present with a referral pattern of pain, not at the site of the trigger 
point origin. A latent trigger point is a sensitive spot that causes pain or discomfort only in 
response to compression.  
 
The trigger point is usually activated by acute or chronic injury to a muscle, tendon, ligament, 
joint, disc or nerve (Hong 1996). Pathogenesis of either referred pain or local twitch response 
is related to integration in the spinal cord. It has been proposed that there are multiple 
sensitive loci in a trigger point region. A sensitive locus may contain one or more sensitized 
nociceptive nerve endings. Mechanical stimulation of a sensitive locus can elicit a local 
twitch response which is frequently associated with characteristic referred pain. 
Theoretically, sensitive loci can be found in any site of a skeletal muscle, but is usually 
distributed with highest concentration near the endplate region where a trigger point is 
frequently found ( Hong 1996) 
Trigger points have been shown to be active in fibromyalgia as well as somatic tenderness 
secondary to visceral dysfunction migraine and other forms of non-pathological headache, 
shoulder, neck, and back pain (Bablis et al 2008). Furthermore, Rosomoff et al (1989) 
demonstrated that 100% of neck pain sufferers possessed the presence of trigger points and 
almost 53% of them had non-dermatomal referral. The studies conducted by  Couppe et al 
(2007) concluded that subjects with chronic headaches had a higher prevalance of TrPs and 
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the presence of TrPs (Fig 1) may be a contributing factor in the initiation and /or prepetuation 
of chronic headaches. An external digital pressure of 3to 4 kg exerted with the thumb, at a 
90-degree angle over TrPs in certain neck muscles, will generally lead to both local and 
spreading head pain outlasting the stimulus with, discomfort or pain spreading to the forehead 
(Antonaci and Sjaastad, 2011). Study conducted by Roth et al (2007) concluded that 
myofascial TrP may be an important pain producing mechanism in cervicogenic headache. 
Davidoff (1998) informed that TrPs of the neck and shoulder muscles contribute to or cause 
recurrent and chronic headaches. Referred pain from TrPs (Jull et al 2009) must be 
considered when evaluating patients with a number of headaches including cervicogenic 
headache (Davidoff 1998).  
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Fig 1. Referred pain patterns from upper trapezius, sternocleidomastoid, sub occipital, 
splenius capitis, splenius cervicis, semispinalis capitis and temporalis muscle trigger points as 
described by Simons & Travell (1999). Picture from Simons D, Travell J, Simons L. Travell 
& Simons  myofascial pain and dysfunction: the trigger point manual, Vol. 1, 2
nd
 edn. 
Baltimore: Williams & Wilkins, 1999. 
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2.7  Physiotherapy treatment of trigger points  
Trigger points are potential outcomes of dysfunction in a region and conventional treatment 
is based around the release of this taut band of skeletal muscle. The treatment of chronic 
myofascial pain requires a comprehensive approach directed to the underlying TrPs source, 
while simultaneously addressing the central importance of perpetuating factors that maintain 
TrP activation (Roth et al 2007). Therapy for TrPs requires an approach that enhances the 
central inhibition through pharmacological or behavioural techniques, and reduces the 
peripheral inputs to the maintenance of the reflexes by utilising physical therapies such as 
exercise, needling and digital pressure (Graff-Radford 2004). Medical management usually 
begins with pharmacologic intervention, however cervicogenic headache patients with trigger 
points frequently do not respond to medications (Page 2011). The aim of physiotherapy 
treatment is to reduce the pain and restore normal function.  Most physiotherapy treatments 
of myofacial pain syndrome are targeted at deactivation of trigger points. Physiotherapy 
techniques in trigger point therapy can be divided into three categories: 
 
1. Manual therapies:  Ischemic compression, spray and stretch, strain and counter strain, 
muscle energy techniques trigger point pressure release, transverse friction massage 
(Fernandez-de-las-Penas et al 2005). 
2. Needling therapies (Fernandez-de-las-Penas et al 2005). 
3. Other techniques: Thermotherapy, ultrasound therapy & laser therapy (Fernandez-de-las-
Penas et al 2005).  
Hou et  al (2002) studies concluded that ischaemic compression therapy, hot packs, stretch 
with spray, TENS,  interferential current  myofascial release technique are effective for 
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easing TrP pain and increasing cervical ROM. Hong et al (1993) studied the immediate 
effects of various physical modalities on pain threshold of an active TrP and concluded that 
all four therapeutic modalities (spray and stretch, superficial heat, ultrasound, deep heat and 
deep pressure soft tissue massage) can be effectively applied for the treatment of myofascial 
pain syndrome to obtain an immediate increase of pain threshold of an active myofascial TrP, 
although the stretch therapy is more effective than the thermotherapy. The various 
physiotherapy techniques and the importance in treating TrPs to reduce pain in headache 
patients are evident from the above studies. 
 
2.8 Measurement Instruments 
2.8.1 Assessing Trigger points using algometer 
In patients who present to the physiotherapist, the use of algometry can be used to reliably 
quantify the tenderness associated with a TrP (Fig 2) and can be used to diagnose their 
location as well as to qualify the degree of pressure sensitivity (Bablis et al  2008).  Reeves et 
al (1986) mentions that once located the quantification of the tenderness (sensitivity) of a TrP 
is imprecise with manual palpation alone but using a pressure algometer adds to the validity 
and reliability.  The results of the study conducted by Delany and McKee (1993) show that 
the pressure threshold meter (algometer) is highly reliable in measuring TrP sensitivity, 
between and within experimenters, and may be useful in the diagnosis and monitoring of 
treatment of myofascial pain syndrome. Reeves  et  al (1986) reported the algometer as a 
reliable instrument in measuring the myofascial trigger point sensitivity and their studies 
concluded significant correlations within experimenter and between experimenter (p<0.01). 
The studies conducted by Kinser et  al (2009)  tested the reliability and construct validity of 
an algometer  by manually applying pressure on a force plate  and the results showed average 
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Pearson (r) correlations between the maximum force reading of the algometer and force plate 
were excellent (r = 0.99)  and recommended that it may be safe to claim that with practice the 
use of algometer is reliable and valid. 
 
Fig 2. Suboccipital region pressure gauge algometer application (Bablis et al 2008) 
 
2.8.2  Assesing pain using  Numeric pain rating scale (NPRS) 
Pain intensity is the most clinically relevant dimension of nearly all forms of headaches and 
accurate reliable measurement of pain is therefore critical to the evaluation of outcome 
measures in headache treatments (Loder and Barch 2012). Initiative on Methods, 
Measurement, and Pain Assessment in Clinical Trials (IMMPACT), twenty seven 
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specialists from academia, governmental agencies, and the pharmaceutical industry 
participated in a consensus meeting and identified core outcome domains that should be 
considered in clinical trials of treatments for chronic pain (Turk et al 2003). There studies 
concluded that chronic pain clinical trials should assess outcomes representing six core 
domains: (1) pain, (2) physical functioning, (3) emotional functioning, (4) participant ratings 
of improvement and satisfaction with treatment, (5) symptoms and adverse events, (6) 
participant disposition. Although consideration should be given to the assessment of each of 
these domains, there may be exceptions to the general recommendation to include all of these 
domains in chronic pain trials (Turk et al 2003).   
 
Although pain is inherently subjective and difficult to measure a number of pain scales have 
been developed and are commonly used in clinical practice and research.  The studies 
conducted by Cork et al (2004) concluded benefits of NPRS over Visual analogue scale 
(VAS). The draw backs of VAS in their studies included increased time consumption, ability 
to understand the abstract concept of the VAS line and then relate it to distance from a zero 
mark (Cork et al 2004). On the other hand NPRS according to their studies is relatively 
simple to understand and thus provide a co relation which is more definitive than a distance 
mark and they recommended it more over VAS on a clinical setting. The 11-point (NPRS) is 
a measure of pain in which patients rate their pain ranging from 0 (no pain) to 10 (worst 
imaginable pain) and it has been shown to have concurrent and predictive validity as a 
measure of pain intensity (Childs et al 2005). The studies conducted by Childs et al (2005) to 
examine the responsiveness characteristics of the numerical pain rating scale (NPRS) in 
patients with low back pain  suggested that clinicians can be confident that a two-point 
change on the NPRS represents clinically meaningful change that exceeds the bounds of 
measurement error. 
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2.8.3 Assessing disability using  The Henry Ford Headache Disability Inventory (HDI) 
The questionnaire was developed by Gary Jacobson, Nabih Ramadan, Sandeep Aggerwal and 
Gary Newman in 1993 at the Henry Ford Hospital, Detroit, MI, USA. It is designed to 
evaluate the self-perceived disability effects (emotional and functional) of headaches on the 
Activities of Daily Living (ADL) and consists of a 25 item questionnaire.  The HDI can be 
used to periodically evaluate a patient with headache to determine the effectiveness of a 
management strategy over time. The domains are emotional (13 items) and functional (12 
items). The participant will be asked questions regarding their headache and should answer 
"yes" sometimes or "no" to each item. For response “yes” 4 points, “no” 0 points and 
“sometimes” 2 points will be allocated. The minimum score is 0, maximum emotional 
subscale is 52, and maximal functional subscale is 48. Maximum score obtainable on the 
index is 100. A higher score on the greater index indicates a higher disability caused by the 
headache.  A decrease in the total HDI of ≥ 29 points as a consequence to a management 
strategy is considered a significant improvement. A person with a low total HDI (< 29 points) 
would not be able to meet the criteria for significant improvement. The developers have 
reported that the 25-item Headache Disability Inventory has good internal consistency 
reliability, robust long-term (2 month) test-retest stability, and good construct validity. In 
1995 they conducted further investigations to evaluate the short-term (1 week) test-retest 
reliability and spouse perceptions of patients' self-perceived headache disability. The short-
term test-retest reliability of the HDI was excellent (Jacobson et al 1995). 
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2.9  Physiotherapy management for cervicogenic headache 
Physical therapy treatment for cervicogenic headaches should be provided by an expert as a 
part of multidisciplinary pain rehabilitation programme (Biondi 2005). Bronfort, et al (2004) 
reviewed the evidence for non-invasive physical treatments for five types of headache 
including “migraine,” “tension-type,” “cervicogenic headache,” a mix of “migraine and 
tension-type,” and “post-traumatic” headache. They found evidence that both neck exercise 
(low-intensity endurance training) and spinal manipulation were effective in the short-term 
and long-term for cervicogenic headaches. Furthermore, evidence-led approach to clinical 
management of cervicogenic headaches consisted of spinal manipulative therapy focusing on 
upper cervical segments, muscle stretching (SCM, upper trapezius, levator, scalenes, 
suboccipitalis, pectoralis major and minor), soft tissue mobilisation and therapeutic exercises 
(Page et al 2011). The findings of a recent study by Bodes- Pardo et al (2013) showed that 
manual therapy targeted to active TrPs in the sternocleidomastoid muscle may be effective 
for reducing headache and neck pain intensity and increasing motor performance of the deep 
cervical flexors, pressure pain threshold, and active cervical range of motion in individuals 
with cervicogenic headache showing active TrPs in this muscle. 
 
Jull et al (2002) studies conducted determined the effectiveness of manipulative 
therapy and a low-load exercise program for cervicogenic headache when used alone and in 
combination on a treatment period of 6 weeks with a follow up session up to twelve months. 
At the 12-month follow-up assessment, both manipulative therapy and specific exercise had 
significantly reduced headache frequency and intensity. Their studies concluded that 
manipulative therapy and exercise can reduce the symptoms of cervicogenic headache, and 
the effects are maintained over a long period of twelve months (Jull et al 2002) 
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2.10  Summary 
This literature review looked at the classification of headaches, cervicogenic headache and its 
pathophysiology. It also discussed the diagnostic criteria of cervicogenic headache, TrPs and 
its importance in headache, physiotherapy treatments to release TrPs, the NPRS, HDI and 
algometer. There is a gap in the literature in comparing the presentation especially the 
sensitivity of TrPs points of cervicogenic and non-cervicogenic group. The results from this 
study may lead to understand the difference in presentation of the both groups so appropriate 
recommendations can be made with regards to the physiotherapy treatment. 
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CHAPTER 3    
3.0 METHODOLOGY 
This chapter describes the methodology used in this research study. It follows a sequence 
from study design, selection of participants, ethical approval, sample size and location of 
study to a full description of the procedure. The pilot study and main study methods will be 
described in separate sections. 
 
 3.1  Study Design  
The study was conducted as a quantitative, cross sectional, descriptive study. 
3.2 Pilot Study 
3.2.1 Introduction 
The pilot study was conducted prior to the main study, aiming for the following: 
1. To minimise the potential errors in the main study. 
2. To identify challenges faced in doing the procedure. 
3. To get familiar with the use of algometer and questionnaire. 
4. Training research assistant in identification of TrPs and differentiating patients into 
cervicogenic and non- cervicogenic group (Appendix i). 
5. To determine inter-examiner reliability in using algometer and differentiating 
participants into cervicogenic and non-cervicogenic groups. 
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3.2.2 Procedure for the Pilot study 
Participants were referred to the researchers practice situated in a private hospital set up in 
Port Elizabeth by medical practitioners for headache treatment. An information session was 
scheduled with the participants where the test procedures and the questionnaires were 
explained. Informed written consent (appendix vi) was obtained from the participants prior to 
the test procedure. A fellow physiotherapist in the same practice who is practising manual 
therapy since 1997 with the researcher was chosen as a research assistant. The research 
assistant had 15 years of experience in manual therapy. The research assistant underwent 16 
hours of training related to the procedure and criteria of the project. All participants were 
assessed by the same research assistant to determine the category to which they belonged. 
The researcher was blinded to this information. Five participants (four females and one male) 
who had headaches and fulfilled the inclusion criteria were selected study the pilot group. 
These five participants were not to be included in the main study. The participants were given 
a unique identification number. The details of the participants were available only to the 
researcher. In order to determine intra-examiner reliability of the algometer the sensitivity of 
TrPs on selected muscles was measured three times each and the average was noted.  
 
3.2.3 Results of the Pilot Study and Recommendations for the Main Study 
The intra-examiner reliability of using the algometer was measured using Pearson 
Correlation(r). Results are between -1 and 1. The closer the value of r gets to zero, the 
greater the variation. High correlation is  0.5 to 1.0 or -0.5 to 1.0,  medium correlation is 0.3 
to 0.5 or -0.3 to 0.5 and low correlation is 0.1 to 0.3 or -0.1 to -0.3 (Bruton et al 2000).The 
intra-examiner reliability of using the algometer was excellent. (r=0.99). This is classified as 
a strong correlation (Reeves et al 1986 and Kinser et  al 2009).  
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The test procedure went well and no changes were made to the procedure for the main study. 
Since both therapists were needed at the time of testing it was decided to call the participant 
to the practice at a time when both therapists were available. It was agreed that the research 
assistant notes the unique study number of the participants and the group they belong and the 
results will only be made available to the researcher during data analysis. This is mainly to 
avoid biased assessment by the researcher towards a particular group while assessment. 
 
3.3 Main Study 
3.3.1 Participants 
3.3.1.1  Inclusion criteria (for both groups) 
The following inclusion criteria were used to recruit voluntary participants and the criteria 
used was in line with the international classification of headaches: 
1. Voluntary individuals aged between 18 to 60 years. 
2. Male or Female. 
3. Headache is not associated with nausea but photophobia and phonophobia may be present. 
4. Headaches usually lasting thirty minutes to 7 days. 
 
3.3.1.2  Exclusion criteria (for both groups) 
Participants with the following will be excluded: 
1. Patients on psychiatric medications. 
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2. Patients who are on medication for headaches 24hrs prior to testing. 
3. Previous surgery to cervical spine. 
4. Patients who are on physiotherapy treatment currently or 4 weeks prior to testing. 
5. Patients with rheumatoid arthritis of the cervical spine. 
6. Patients with tumours on the neck \head area. 
7. Patients suffering from severe acute migraine attacks (diagnosed according to IHS 2004). 
8. Patients who complain of medication overuse headache(diagnosed according to IHS 2004). 
9. Patients with communications problems that will prevent them from reporting on the level 
of pain during the trigger point sensitivity threshold testing. 
 
3.3.1.3  Participant recruitment and setting 
The participants were patients referred for physiotherapy (who fits the same inclusion and 
exclusion criteria as referred to in the pilot study) at a practice in Mercantile Private Hospital 
from Nov 2012 to June 2013. Invitation to refer patients was given to medical practitioners 
who include general practitioners, physicians, orthopaedic surgeons, neurosurgeons and 
physiotherapists in Port Elizabeth Metropole. A brief description of the study along with the 
inclusion and exclusion criteria was given to the other medical practitioners in Port Elizabeth 
(appendix iv). They were informed that participation is voluntary and the participants may 
refuse to participate at any stage during the study and there were no financial implications to 
the practitioner or the patient involved in this research study. It was advised that participants 
will be asked to refrain from any pain or anti-inflammatory medication 24 hours preceding 
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the testing procedure and refusal to participate will not bear any penalty or loss of benefits to 
which the participant is otherwise entitled. 
 
3.3.2  Sample Size 
An expected rate of positive trigger points in cervicogenic group was calculated at 70% and 
25% for non cervicogenic group (Page 2011). A power calculation of 80% suggested that the 
sample size of 20 per group. Twenty participants with cervicogenic headaches and twenty 
participants with non cervicogenic headaches were recruited for this study. This is in 
accordance with similar studies conducted by Zito et al (2006) on clinical tests of 
musculoskeletal dysfunction in the diagnosis of cervicogenic headache and Hong et al  
(2010) on clinical assessment of patients with cervicogenic headaches. 
 
3.3.3 Instrumentation and outcome measure 
A hand-held digital algometer was used to measure the sensitivity of TrPs (Appendix viii) 
and The Henry Ford Hospital Headache Disability Inventory (HDI) questionnaire (Appendix 
ix) was used to measure the level of disability due to headaches. 
 
3.3.3.1 Details of the Algometer 
A hand-held digital algometer with 1cm
2
 round head was used (J Tech Medical; 470, 
Lawndale Drive, Salt Lake City, UT 84115, USA). The algometer was supplied by 
Physiotherapy Department of the University of the Witwatersrand. According to the 
information provided by J Tech Medical, USA, calibration is not required every year, the 
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accuracy of the device can be gauged by applying a known weight to the device. A known 
weight was applied to the algometer to check the accuracy of the device and no variation was 
noted. The device was set to zero reading before taking each measurement. 
 
3.3.3.2 The Henry Ford Headache Disability Inventory 
The questionnaire Henry Ford Headache Disability Inventory (appendix ix) developed by 
Gary Jacobson, Nabih Ramadan, Sandeep Aggerwal and Gary Newman in 1993 at Henry 
Ford Hospital, Detroit, MI, USA (Jacobson et al 1994) It is designed to evaluate the self-
perceived disability effects (emotional and functional) of headaches on the Activities of Daily 
Living (ADL).  
 
3.3.4 Procedure Protocol 
The researcher arranged meetings with the referring doctors at the Port Elizabeth Metropole. 
A detailed explanation of the project was provided and the information sheet for referring 
medical practitioners was handed to the doctors.  To maximise the sample size the researcher 
also contacted other physiotherapists and medical practitioners via telephone and the project 
details were e-mailed to them. An information session was arranged by the researcher to the 
participants prior to the testing. Each participant was given the information document that 
explained the study and written informed consent was obtained from each participant. The 
participants were asked not to take any pain and anti-inflammatory medication during the 24 
hours preceding evaluation.  
After completing the demographic questionnaire (appendix x) clinical information regarding 
the duration of headache and level of pain was noted. Assessment of pain was based on a 
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NPRS (appendix xi). The research assistant then assessed the participant to determine which 
group they belonged to and the researcher was blinded to this information. The researcher 
then explained the HDI (appendix ix) questionnaire and the participants were asked to 
complete it. The researcher had arranged translator for the HDI and NPRS in case any of the 
participants had difficulty in understanding English. But all the participants who came for the 
study were able to express their disabilities in English.  Neither the research assistant, nor the 
researcher looked at the questionnaire information before or during patient assessment. The 
participants were then  seated and was examined by the researcher ( standing)  for presence of 
one active TrP the upper trapezius, sternocleidomastoid, posterior cervical muscles & 
temporalis (according to Simons and Travell 1999) mainly by using thumbs and index finger 
and patients responds by referred pain when pressing on the trigger points. The selected 
muscle that did not have TrPs  was marked “N” next to the muscle on the data collection 
sheet (appendix x). After locating the trigger points the algometer with a round tip of 1cm
2
 
was positioned at the physically located trigger points. Compression pressure was gradually 
increased perpendicularly on the muscle and a measurement (the reading which is the 
minimal pressure needed to elicit pain) was taken. The reading on all located trigger points 
was taken three times by re-setting the machine for each of the three readings at each of the 
points. The researcher recorded the name of the muscle and algometer reading as well as the 
level of pain the participant experienced.  
 
3.4  Data Analysis 
The variables tested in the study are: 
 a) Pressure threshold of the trigger points in the following muscles in kg\cm
2
: Upper 
trapezius, SCM, posterior cervical muscles and temporalis (continuous data).  
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b) HDI questionnaire (categorical data).  
c) Participants demographic data (Age, Sex, Height, Weight & BMI) (continuous data) and  
d) Participants pain response in numeric pain rate scale (0 to 10) (categorical data) and 
duration of headache (continuous data). 
 The data of both the groups were entered to an Excel sheet. The cervicogenic group were 
compared to the non-cervicogenic group in terms of the above mentioned continuous 
variables using the Student t-test and the categorical data were compared using the Chi-
Square test at a 5% level of significance. The data was analysed using STATA version 12 
(Data Analysis and Statistical Software). Descriptive analysis was used to establish the 
distribution of data and all data were normally distributed. Effect sizes were calculated using 
Cohen’s d where effect sizes of 0.2, 0.5 and 0.8 were interpreted as small, medium and large, 
respectively (Cohen 1992). The results will be discussed in the following chapter.  
 
3.5 Ethical considerations 
Application for ethical clearance was granted by the Human Research Ethics committee of 
the University of the Witwatersrand before the collection phase commenced. (Appendix ii). A 
signed informed consent (Appendix iii) was mandatory and obtained from each participant 
prior to the testing procedure. Detailed information regarding the purpose of the study and the 
diagnosing criteria (Appendix iv) was given to the medical practitioners and physiotherapists 
referring participants for this study. Each participant was given a unique identification 
number (to maintain strict confidentiality throughout the study) and patient information sheet 
(appendix v). Participants were re-reimbursed the transport cost from their homes if they had 
to use public transport to attend the study. 
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CHAPTER 4    
4.0 RESULTS 
In this chapter, the results will be presented in the order of objectives of the study. 
4.1 Descriptive characteristics of the study population 
TABLE 4.1 Demographic representation of the cervicogenic & non-cervicogenic groups 
Variable Cervicogenic (n=20) 
n(%) 
Non-cervicogenic 
(n=20) n (%) 
p-value (<0.05) 
Gender   0.15 
  Male 1.0 (5.0) 4 (20.0)  
  Female 19.0 (95.0) 16 (80.0)  
 
TABLE 4.2 Descriptive characteristics of the cervicogenic & non-cervicogenic groups 
Variable Cervicogenic (n=20) 
 
Non-cervicogenic 
(n=20)  
p-value (<0.05) 
Age (yrs)   0.08 
 Mean (±SD) 36.5 (±8.38) 41.2 (± 8.21)  
BMI(kg/m
2
)   0.37 
  Mean (±SD) 29.8 (±6.0) 28.0(±6.0)  
Duration (months)   0.88 
  Mean (±SD) 34.5(±42.54) 32.6(±35.9)  
 
Table 4.1 and 4.2 shows the results for the descriptive characteristics of the two groups of 
participants (cervicogenic and non-cervicogenic) that participated in the study. Among the 
cervicogenic group, females constituted 95% (n=19) while 80% (n=16) were females in the 
non-cervicogenic group. The average age of cervicogenic participants was 36.5 (±8.38)  years 
compared to 41.2 (±8.21)  years in the non-cervicogenic participants 
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4.2   Presence of trigger points and  sensitivity comparison between both groups 
TABLE 4.3 TrP Sensitivity in cervicogenic and non-cervicogenic groups (kg/cm
2 
) 
Variable Cervicogenic 
(n=20) 
Non-cervicogenic 
(n=20) 
p-value (<0.05) 
Right upper trapezius(SD) 13.4(±8.8) 20.3(±9.8) 0.02 
Right 
sternocleidomastoid(SD) 
11.4(±5.6) 13.6(±5.5) 0.22 
Right temporalis(SD) 12.8(±7.1) 16.2(±7.7) 0.16 
Right posterior cervical 
muscles(SD) 
13.95.(±8.0) 17.35(±9.0) 0.21 
Left upper trapezius(SD) 11.7(±7.2) 20.4(±8.2) 0.01 
Left 
sternocleidomastoid(SD) 
9.0(±3.0) 9.0(±3.5) 1.00 
Left temporalis(SD) 9.6(±5.5) 12.2 (±7.0) 0.12 
Left posterior cervical 
muscles(SD) 
14.3(±7.9) 16.5(±9.2) 0.41 
 
Sensitivity of the active TrP on the selected muscles was established and table 4.1 compares 
sensitivity of trigger points between cervicogenic and non-cervicogenic participants. The 
lowest algometer reading in cervicogenic group was 0.57kg/cm
2
 and the highest was 
2.6kg/cm
2
. In non-cervicogenic group the lowest reading was 0.55kg/cm
2
 and the highest was 
6.6kg/cm
2
. The table shows the mean reading in kg/cm
2
 in each muscle of both the groups. 
Results found evidence of a statistically significant difference between the two groups with 
respect to trigger points sensitivity in right upper trapezius (p=0.02; effect size d = 0.74) as 
well as left upper trapezius (p=0.01; effect size d = 1.13) muscles. Therefore, since 
cervicogenic participants had a lesser mean sensitivity score, it implies that trigger points 
sensitivity were significantly higher in cervicogenic participants than non- cervicogenic 
participants in the right upper trapezius and the left upper trapezius. 
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4.3  A comparison of the cervicogenic and non-cervicogenic groups in terms of self-
perceived disability 
TABLE 4.4 Total HDI score and pain rating scale of both groups 
Variable Cervicogenic 
n=20 
Non-
cervicogenic 
n=20 
p-
value(<0.05) 
Functional score    
  Mean (±SD) 31.9(±11.8) 34.4(±10.0) 0.47 
Emotional score    
  Mean (±SD) 30.3(±10.9) 30.8(±12.3) 0.89 
Total score    
  Mean (±SD) 62.2(±21.5) 65.2(±21.1) 0.66 
Pain scale (0 to 10)    
  Mean (±SD) 7.0(±1.5) 6.3(±1.1) 0.12 
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TABLE 4.5 The HDI - Emotional Items in cervicogenic and non-cervicogenic groups 
Variable Cervicogenic 
n=20 
Non-
cervicogenic 
n=20 
p-
value(<0.05) 
Because of my headaches I feel handicap   0.24 
  more than 1 per week 6(30.0) 2(10.0)  
  more than 1 but less  than 4 for month 14(70.0) 18(90.0)  
No one understands the effect that my headaches have on my 
life 
  0.24 
  No 4(20.0) 9(45.0)  
  Yes 7(35.0) 6(30.0)  
  Sometimes 9(45.0) 5(25.0)  
My headaches make me angry   0.74 
  No 5(25.0) 5(25.0)  
  Yes 13(65.0) 11(55.0)  
  Sometimes 2(10.0) 4(20.0)  
Sometimes I feel that I am going to lose control because of 
my headaches 
  0.36 
  No 9(45.0) 5(25.0)  
  Yes 8(40.0) 9(45.0)  
  Sometimes 3(15.0) 6(30.0)  
My spouse(significant other) or family and friends have no 
idea what I am going through because of my headaches 
  0.79 
  No 6(30.0) 4(20.0)  
  Yes 7(35.0) 7(35.0)  
  Sometimes 7(35.0) 9(45.0)  
My headaches are so bad that I feel I am going insane   0.29 
  No 3(15.0) 6(30.0)  
  Yes 10(50.0) 11(55.0)  
  Sometimes 7(35.0) 3(15.0)  
My outlook on the world is affected by my headaches   1.00 
  No 6(30.0) 6(30.0)  
  Yes 10(50.0) 11(55.0)  
  Sometimes 4(20.0) 3(15.0)  
I am afraid to go outside when I feel that a headache is 
starting 
  0.71 
  No 11(55.0) 8(40.0)  
  Yes 3(15.0) 5(25.0)  
  Sometimes 6(30.0) 7(35.0)  
My headaches place stress on my relationship with family or 
friends 
  0.34 
  No 5(25.0) 5(25.0)  
  Yes 8(40.0) 12(60.0)  
  Sometimes 7(35.0) 3(15.0)  
I feel irritable because of my headaches   0.27 
  No 3(15.0) 0(0.0)  
  Yes 15(75.0) 17(85.0)  
  Sometimes 2(10.0) 3(15.0)  
I feel desperate because of my headaches.   0.50 
  No 0(0.0) 1(5.0)  
  Yes 12(60.0) 14(70.0)  
  Sometimes 8(40.0) 5(25.0)  
My headaches make me feel confused   0.62 
  No 7(35.0) 6(30.0)  
  Yes 9(45.0) 7(35.0)  
  Sometimes 4(20.0) 7(35.0)  
My headaches make me feel frustrated   0.88 
  No 2(10.0) 2(10.0)  
  Yes 13(65.0) 15(75.0)  
  Sometimes 5(25.0) 3(15.0)  
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TABLE 4.6 The HDI -Functional Items in cervicogenic and non-cervicogenic groups 
Variable Cervicogenic 
n=20 
Non-
cervicogenic 
n=20 
p-
value(<0.05) 
Because of my headaches I feel restricted in performing my 
daily routines 
  1.00 
  Mild 2(10.0) 3(15.0)  
  Moderate 7(35.0) 6(30.0)  
  Severe 11(55.0) 11(55.0)  
I restrict my recreational activities (e.g. sports hobbies) 
because of my headaches 
  0.89 
  No 2(10.0) 2(10.0)  
  Yes 11(55.0) 9(45.0)  
  Sometimes 7(35.0) 9(45.0)  
Because of my headaches I am less likely to socialize   0.85 
  No 5(25.0) 6(30.0)  
  Yes 7(35.0) 8(40.0)  
  Sometimes 8(40.0) 6(30.0)  
I am concerned that I am paying penalties at work or at 
home because of my headaches 
  0.67 
  No 4(20.0) 6(30.0)  
  Yes 9(45.0) 9(45.0)  
  Sometimes 7(35.0) 5(25.0)  
I avoid being around people when I have a headache   0.71 
  No 8(40.0) 5(25.0)  
  Yes 8(40.0) 10(50.0)  
  Sometimes 4(20.0) 5(25.0)  
I believe my headaches are making it difficult for me to 
achieve my goals in life 
  0.05 
  No 4(20.0) 3(15.0)  
  Yes 14(70.0) 8(40.0)  
  Sometimes 2(10.0) 9(45.0)  
I am unable to think clearly because of my headaches   0.81 
  No 5(25.0) 4(20.0)  
  Yes 12(60.0) 14(70.0)  
  Sometimes 3(15.0) 2(10.0)  
I get tense (e.g. muscle tension) because of my headaches   0.21 
  No 7(35.0) 2(10.0)  
  Yes 8(40.0) 11(55.0)  
  Sometimes 5(25.0) 7(35.0)  
 
I do not enjoy social gatherings because of my headaches 
  0.59 
  No 4(20.0) 4(20.0)  
  Yes 12(60.0) 9(45.0)  
  Sometimes 4(20.0) 7(35.0)  
I avoid travelling because of my headaches   1.00 
  No 6(30.0) 5(25.0)  
  Yes 10(50.0) 11(55.0)  
  Sometimes 4(20.0) 4(20.0)  
I find it difficult to read because of my headaches   0.74 
  No 3(15.0) 1(5.0)  
  Yes 15(75.0) 16(80.0)  
  Sometimes 2(10.0) 3(15.0)  
I find it difficult to focus my attention away from my 
headaches and on other things 
  0.43 
  No 4(20.0) 2(10.0)  
  Yes 13(65.0) 12(60.0)  
  Sometimes 3(15.0) 6(30.0)  
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The average functional score for cervicogenic participants was 31.9% (n=20) while a mean 
functional score of 34.4% (n=20) was recorded in non-cervicogenic participants. However, 
the difference in mean scores did not attain statistical significance. A similar pattern of higher 
average emotional score and average total score was observed in non-cervicogenic 
participants. Results also showed that 30% (n=6) of cervicogenic participants felt 
handicapped by their headaches more than once per week compared to only 10% (n=2) in the 
non-cervicogenic group. However no statistical evidence of significant difference was found 
between the two groups. Response patterns were found to be similar between cervicogenic 
and non-cervicogenic participants across the HDI items with no evidence of statistically 
significant difference between them (Table 4.4).  The mean pain scale score in cervicogenic 
participants was 7.0 compared to 6.3 in non-cervicogenic participants For all these 
characteristics, difference between cervicogenic and non-cervicogenic participants did not 
attain statistical significance (p<0.05).  
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4.4 CONCLUSION 
The results from the current study found  evidence of a statistically significant difference with 
respect to trigger points sensitivity in right upper trapezius (p=0.02) and left upper trapezius 
(p=0.01) muscles, implying that trigger points sensitivity were significantly higher in 
cervicogenic participants than non-cervicogenic participants in the right upper trapezius and 
the left upper trapezius. Trigger points sensitivity were found to be higher in the left SCM 
and left temporalis in cervicogenic participants although this did not reach statistical 
significance. The results further more revealed a response pattern found to be similar between 
cervicogenic and non-cervicogenic participants across the HDI items with no evidence of 
statistically significant difference between them. The cervicogenic and non-cervicogenic 
groups were similar in terms of descriptive characteristics. The implication of results 
contained in this chapter will be discussed in the following chapter. 
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CHAPTER 5 
5.0 DISCUSSION 
This chapter focuses on the discussion of the results of the study outlined in Chapter 4 and 
how these findings relate to other research findings. 
 
5.1   Demographic Data 
The study examined a total of 40 participants, 20 with cervicogenic headache and 20 non- 
cervicogenic headache. The physical characteristics of the participants in this study show 
very close similarities to those of other studies. For demographics (gender & age) and 
physical (BMI & duration) characteristics, differences between cervicogenic and non- 
cervicogenic participants did not attain statistical significance (p<0.05). These results are in 
accordance with studies conducted by Hong et al (2010) who examined 22 cervicogenic 
headache subjects with 14 healthy subjects and found no statistical difference in gender, age 
and BMI between both groups. A similar study done by Zito et al (2011) on musculoskeletal 
dysfunction in diagnosing cervicogenic headache examined cervicogenic headache, migraine 
with aura and control subjects found no difference in mean age and duration of headaches 
between the groups. Among the cervicogenic group, females constituted 95% (n=19) with a 
mean age of 36.5 years which is in accordance with Page (2011) & Hall et al (2008)where 
85-88 % female predominance in cervicogenic patients was mentioned. The female 
predominance in majority of the studies can be associated with hormonal shifts (Page 2011) 
or the fact that females tend to seek medical attention more than men (Hall et al 2008). This 
may also be the case in the current study as more females suffered from headaches. 
Similarities in the descriptive characteristics of both groups suggest that both types of 
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headaches cannot be differentiated in terms of a specific age, sex, body mass index, pain 
intensity or level of disability. 
5.2 Trigger point sensitivity in participants with cervicogenic headaches and 
participants with non-cervicogenic headaches 
The results of this study found evidence of a statistically significant difference with respect to 
trigger points sensitivity in right upper trapezius (p=0.02) and left upper trapezius (p=0.01) 
muscles when comparing cervicogenic and non-cervicogenic participants. In addition to 
statistical significance, an effect size (Cohen’s d)  of 0.74 for the right and 1.13 for the left 
upper trapezius which can be classified as a medium and large effect size, respectively The 
algometer reading or TrP sensitivity value is low when the patent can only handle a minimal 
amount of pressure (threshold) before pain is felt. Therefore, since cervicogenic headache 
participants had a lesser mean sensitivity score (lower the algometer reading, higher is the 
sensitivity of TrPs), this implies that trigger points sensitivity were significantly higher in 
cervicogenic participants than in non-cervicogenic participants in both the right upper 
trapezius and the left upper trapezius.Couppe´ et al (2007) reported similar results in a group 
of twenty patients with the diagnosis of chronic tension type headaches (CTTH), and 20 
healthy age-matched and sex-matched control participants. The control group was blinded to 
the examiner and the participants were advised not to take any analgesic drug or muscle 
relaxants 24hrs before the examination. The TrPs sensitivity was measured using VAS and 
NPRS. The results of the mentioned study suggest that TrP palpation revealed more TrPs in 
patients (n=17) versus controls (n=6). Referred pain was also more frequent in patients 
(n=17) versus controls (n=9). Pain intensity of TrPs in patients was higher than in control 
group. The study concluded that   number and pain intensity of TrPs may be used to 
distinguish between the two groups. The increased myofascial tenderness by palpation or 
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movement was shown to be positively correlated to intensity and frequency of headache. The 
findings of the study by Couppe´ et al (2007) suggests that  increased sensitivity of TrPs 
correlates to the intensity and frequency of headache. Similarly in this study the increased 
sensitivity of TrPs in upper trapezius may be used as an additional factor to distinguish 
between both groups. 
 
 Page (2011) also reported that cervicogenic headache patients have a high probability of 
having myofascial trigger point pain particularly from over-activity of the SCM, upper 
trapezius, and temporalis which can be due to forward head posture and decreased endurance 
of the deep neck flexors. Myofascial TrPs of the SCM have a similar referred pain pattern to 
that seen in cervicogenic headaches (posterior to frontal). In addition, he reported that all 12 
cervicogenic headache patients had at least three myofascial trigger points on their 
symptomatic side which reproduced their headaches over 50% of the time. The reason for 
this in these patients is that pain thresholds are decreased where the local tenderness is 
increased represented by a segmented central sensitisation or supraspinal modulation of 
incoming stimuli (Page 2011). 
 
 Jull et al (1999) tested the upper cervical muscle tightness of 15 cervicogenic subjects and 
found significantly higher muscle tightness was found in upper trapezius of the cervicogenic 
group. Page (2011) suggests that the tightness in upper trapezius can be associated to the 
forward head posture (upper crossed syndrome) of cervicogenic headache patients. Antonaci 
and Sjaastad (2011) also mentions increased upper trapezius sensitivity in cervicogenic 
patients. Postural adaptations may play a role in the development of the TrPs in the upper 
trapezius muscles associated with especially a forward head posture. 
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5.3   A comparison of the cervicogenic and non-cervicogenic groups in terms of self-
perceived disability  
Response patterns were found to be similar between cervicogenic and non-cervicogenic 
participants across the HDI items with no evidence of statistically significant difference 
between them. It can however be seen that some time was lost (due to time taken off from 
work due to headaches) by cervicogenic participants who felt handicapped by their headaches 
more than once per week compared to only 10% (n=2) in the non- cervicogenic group. This 
could have severe economic implications for both employer and employee. Hall, et al (2008 
)mentions that although the prevalence of cervicogenic group is considerably lower than 
tension type headache and migraine, patients with cervicogenic headache have a substantial 
quality-of- life burden, comparable to patients with migraine and tension-type headache. 
Even though this study was not compared to migraine and tension type only, the results from 
the self-perceived disability (HDI) showed that quality of life burden of cervicogenic group 
was as equal to the non cervicogenic groups.  Van Svijlekom et al (2003) conducted a study 
with a similar questionnaire on thirty-seven patients with cervicogenic headache, 42 patients 
with episodic tension-type headache, and 39 patients with migraine without aura. The 
objective of their study was to establish the health related quality of life of cervicogenic 
group. Their studies concluded that patients with cervicogenic headache demonstrate that the 
impairment of quality of life in those with cervicogenic headache is worse compared to 
healthy persons but is, in general, comparable with patients with migraine and tension type 
headache (Van Svijlekom et al 2003).  
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5.4  Conclusion 
This chapter discussed the major findings of this study in comparing the presentation of 
cervicogenic and non-cervicogenic group. The pressure pain threshold (sensitivity) of TrPs in 
the upper trapezius muscles may be used as an additional factor to differentiate   between 
cervicogenic and non-cervicogenic headaches. Both the cervicogenic and non-cervicogenic 
groups showed a similar level of disability, which may have economic implications for both 
employer and employee. Descriptive characteristics of both cervicogenic and non-
cervicogenic groups revealed similar results showing female predominance in both groups. 
Limitations and recommendations from the whole study are highlighted in the next chapter 
(chapter 6). 
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CHAPTER 6 
6.0  CONCLUSION 
Headache is one of the most common disorders of the nervous system and several of its 
subtypes lead to substantial levels of disability. This study compares the presentation of 
cervicogenic and non-cervicogenic headache. The level of disability between both groups is 
compared using HDI. Similarities in the descriptive characteristics, pain intensity and level of 
disability of both groups suggest that both types of headaches cannot be differentiated in 
terms of a specific age, sex, body mass index, pain intensity or level of disability. Increased 
sensitivity of TrPS in upper trapezius may be used as an additional diagnosing factor of 
cervicogenic headache group. 
 
6.1  Study limitations 
The cervicogenic and non-cervicogenic groups participants were not matched by age and 
gender due to the difficulty in finding patients that fitted the criteria of this study. However, 
the difference between these two groups was not significant as shown in table 4.5. The study 
of headache disability assessment was done only using HDI in both groups.  
 
6.2  Clinical recommendation  
From the above study it is recommended that cervicogenic headaches cannot be differentiated 
from non-cervicogenic headaches in terms of a specific age, sex, body mass index, pain 
intensity or level of disability. Increased sensitivity of trigger points in upper trapezius may 
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be used as an additional diagnosing factor of cervicogenic headache group. Since 
physiotherapy treatment regime are indicated in treating TrPs the presence of TrPs in upper 
trapezius in cervicogenic headache patients indicate the benefits of physiotherapy in treating 
these patients. 
6.3  Recommendations for future research 
More research is needed to compare the sensitivity of TrPs in other forms of headaches. The 
role of upper trapezius fiber trigger points sensitivity on the frequency and duration of 
cervicogenic headache needs to be investigated. More research is needed Neuro muscular 
management techniques in effective management of cervicogenic headaches. Other methods 
of assessment of pain and disability in cervicogenic headaches and the validity of tools used 
in South African population needs to be investigated. 
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Appendix i        Diagnosis of cervicogenic headaches 
Cervicogenic patients were differentiated from non cervicogenic patients by using the 
diagnostic criteria used by Zito et al (2006) and the clinical characteristics explained by 
Biondi,( 2005). The clinical characteristics are: 
1. Unilateral head or face pain without side shift; the pain may occasionally be bilateral 
2.  Pain localized to the occipital, frontal, temporal or orbital regions 
3. Moderate to severe pain intensity 
4. Intermittent attacks of pain lasting hours to days, constant pain or constant pain with 
superimposed attacks of pain 
5.  Pain is generally deep and non-throbbing; throbbing may occur when migraine attacks 
are superimposed 
6. Head pain is triggered by neck movement, sustained or awkward neck postures; digital 
pressure to the sub occipital, C2, C3, or C4 regions or over the greater occipital nerve; 
valsalva cough or sneeze might also trigger pain 
7. Restricted active and passive neck range of motion; neck stiffness 
8. Associated signs and symptoms can be similar to typical migraine accompaniments 
including nausea, vomiting, photophobia, phonophobia and dizziness. 
Zito et al (2006) manual examination criterion for identifying cervicogenic headache patients 
consists of: 
1. measurement of cervical flexion and extension (according to Knackstedt et al 2007 
decreased  at least by 20 degrees in cervicogenic group) 
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2. manual assessment of O/C1, C1/C2,C2/C3 (painful segmental dysfunction in 
cervicogenic group) 
3. muscle extensibility- Upper trapezius, Scalenes, Levator Scapulae, Short Cervical 
Extensors, Pectoris major & minor ( muscle tightness higher in cervicogenic group) 
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Appendix ii  Ethics Committee Clearance Certificate 
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Appendix iii                     Informed consent form 
I hereby confirm that I have been informed about the details of the study  
“A comparison of the presentation of patients with cervicogenic headaches and patients 
with non-cervicogenic headaches” done by Mr. Abraham Pramod.  
I have had sufficient opportunity to ask questions and declare myself prepared to participate 
in the study. 
I give consent to perform palpation techniques to my neck muscles and to apply pressure by 
means of a digital hand- held algometer. 
I understand that I can withdraw from the study at any time without giving any reasons to the 
researcher. 
PARTICIPANT 
…………………………………………………………………………….. 
Printed Name                      Signature                                 Date and Time 
I, Abraham Pramod, herewith confirm that the above participant has been fully informed 
about the details of the above study 
RESEARCHER 
…………………………………………………………………………….. 
Printed Name                        Signature                               Date and Time 
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Appendix iv       Information sheet to referring medical practitioners 
“A comparison of the presentation of patients with cervicogenic headaches and patients 
with non-cervicogenic headaches” 
Dear colleague 
My name is Abraham Pramod, I am a registered physiotherapist doing my Master’s Degree 
In Physiotherapy at the University of the Witwatersrand. I am conducting research on the 
presentation of patients with cervicogenic headaches and non-cervicogenic headaches. By 
determining the presentation of the two groups the researcher wants to determine the effect of 
physiotherapy treatment in both groups since physiotherapist plays a huge role in treating 
headache patients. 
I would like you to take part in the study by referring your patients that suffer from 
headaches. The following information will give you the criteria of referral. 
Inclusion Criteria (for both groups) 
1. Voluntary Individuals aged between 18 to 60 years 
2. Male or Female 
3. Headache is not associated with nausea but photophobia and photophobia may be present 
4. Headaches usually lasting thirty minutes to 7 days 
Exclusion Criteria (for both groups) 
1. Psychiatric patients on medication  
2. Patients who are on medication for headaches24hrs prior to testing 
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3. Previous surgery to cervical spine 
4. Patients who are on physiotherapy treatment currently or 4 weeks prior to testing 
5. Patients with rheumatoid arthritis of the cervical spine 
6. Patients with tumours on the neck \head area 
7. Patients suffering from severe acute migraine attacks 
8. Patients who complain of medication overuse headaches 
9. Patients with communications problems that will prevent them from reporting on the level 
of pain during the trigger point sensitivity threshold testing. 
 All the participants will be asked to fill in questionnaires relating to their headache, as 
well as sign written informed consent.  Confidentiality will be maintained through-out the 
study and each participant will be allocated a number to conceal their identity.    The 
procedure will not take more than an hour of their time. Participation is voluntary and you 
may refuse to participate at any stage during the study .There is no financial implication 
to you or the patient, in this research study.  Please be advised that participants will be 
asked to refrain from any pain or anti-inflammatory medication 24hours preceding the 
testing procedure  Refusal to participate will not bear any penalty or loss of benefits to 
which the participant is otherwise entitled. The participant will be offered a treatment 
session free of charge following the assessment. 
 For further information and questions regarding the study please do not hesitate to contact 
me: 
      Abraham Pramod 
      Email: apramodpt@gmail.com 
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      Tel: 041 4536385 
      Cell: 0832345778 
 Or information regarding ethical consideration can be obtained from the chairman of the 
Human research ethics committee (medical), University of the Witwatersrand, 
Johannesburg, Prof. P.E Cleaton Jones, Tel 011 7171234. 
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Appendix v                 Information sheet to participants 
 
A comparison of the presentation of patients with cervicogenic headaches and patients 
with non-cervicogenic headaches 
Introduction 
Good day, my name is Abraham Pramod, am a registered physiotherapist and currently a 
postgraduate student at the University of the Witwatersrand, Johannesburg. I am conducting 
research on the presentation of patients with headaches. I would like to invite you to 
participate in the research study. Before agreeing to participate I would like you to read and 
understand the following explanation of the purpose of the study, the study procedures, 
benefits and risks. If you have any questions please do not hesitate to ask. 
Purpose of study 
The purpose of the study is to determine if the sensitivity of trigger points (knots) in the 
various neck muscles are the same in patients with different types of headaches which will 
determine the efficiency of physiotherapy treatment in different groups of headache patients 
Procedures 
If you have agreed to participate in the study, you will be required to fill in a questionnaire 
containing questions about your headaches. You will be evaluated by a registered 
physiotherapist and the whole procedure should not take more than an hour of your time. 
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Risks and Discomforts 
This study has no risks. After the evaluation process you might experience some discomfort 
and tenderness on the neck muscles and these symptoms should not present for more than 
24hrs. 
Benefits and/Compensation 
The benefits of this study will give us a better understanding of the trigger points in 
headaches. You will not be paid to participate in the study. You will be reimbursed the travel 
expense to participate and catering on the day of testing will be provided as a token of my 
appreciation for your time. You will be offered a treatment session free of charge following 
the assessment. 
Voluntary Participation 
Participation in this study is voluntary. If you decide not to participate in this study, your 
decision will not involve a penalty and you are free to withdraw at any time. You have the 
right to decline to answer any questions that you are not comfortable with. 
Confidentiality 
Efforts will be made to ensure absolute confidentiality of your name and personal 
information. 
Contacts and Questions 
For further information and questions regarding the study please do not hesitate to contact 
me: 
Abraham Pramod 
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Email: apramodpt@gmail.com 
Tel: 041 4536385 
Cell: 0832345778 
 
Or information regarding ethical consideration can be obtained from the chairman of the 
Human research ethics committee (medical), University of the Witwatersrand, Johannesburg, 
Prof. P.E Cleaton Jones, Tel 011 7171234. 
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Appendix vi                   Algometer Report 
 
Name:__________________________Date :__/__/____Examiner:________________ 
Right Side 
Pressure Threshold REP1 REP2 REP3 AVG 
  Upper Trapezius     
Sternocleidomastoid     
Temporalis     
Posterior Cervical Muscles     
Left Side 
Pressure Threshold REP1 REP2 REP3 AVG 
  Upper Trapezius     
Sternocleidomastoid     
Temporalis     
Posterior Cervical Muscles     
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Appendix vii            Headache Disability Index 
 
 
HEADACHE DISABILITY INDEX QUESTIONNAIRE 
Name:____________________ 
ID#: _______________ 
Ref. Dr:___________________ 
Age: _______ 
Date: _______ 
Gender: M / F 
INSTRUCTIONS: Please CHECK the correct response: 
1. I have headaches:         1 per month       more than 1 but less than 4 per month 
2. My headache is: mild moderate severe 
more than 1 per week 
INSTRUCTIONS: (Please read carefully): The purpose of the scale is to identify difficulties that you may be experiencing because of your 
headache. Please check off "YES," "SOMETIMES," or "NO" to each item. Answer each question as it pertains to your headache only. 
YES  SOMETIMES   NO 
E1. Because of my headaches I feel handicapped. 
F2. Because of my headaches I feel restricted in performing my routine daily activities. 
E3. No one understands the effect my headaches have on my life. 
F4. I restrict my recreational activities (eg, sports, hobbies) because of my headaches. 
E5. My headaches make me angry. 
E6. Sometimes I feel that I am going to lose control because of my headaches. 
F7. Because of my headaches I am less likely to socialize. 
E8. My spouse (significant other), or family and friends have no idea what I am going through because of my 
headaches. 
E9. My headaches are so bad that I feel that I am going to go insane. 
E10. My outlook on the world is affected by my headaches. 
E11. I am afraid to go outside when I feel that a headache is starting. 
E12. I feel desperate because of my headaches. 
F13. I am concerned that I am paying penalties at work or at home because of my headaches. 
E14. My headaches place stress on my relationships with family or friends. 
F15. I avoid being around people when I have a headache. 
F16. I believe my headaches are making it difficult for me to achieve my goals in life. 
F17. I am unable to think clearly because of my headaches. 
F18. I get tense (eg, muscle tension) because of my headaches. 
F19. I do not enjoy social gatherings because of my headaches. 
E20. I feel irritable because of my headaches. 
F21. I avoid traveling because of my headaches. 
E22. My headaches make me feel confused. 
E23. My headaches make me feel frustrated. 
F24. I find it difficult to read because of my headaches. 
F25. I find it difficult to focus my attention away from my headaches and on other things. 
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Appendix viii                   Demographic questionnaire 
1. Name: 
2. Age: 
3. Sex: 
4. Race ( for statistical purposes only): 
5. Area of residence: 
6. Occupation: 
7. Duration of headache : 
8. Height: 
9. Weight: 
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Appendix ix- Numeric Pain Rating Scale (NPRS) 
0 – 10 Numeric Rating Scale  
 
 
 
 
0 1 2 3 4 5 6 7 8 9 10 
▲ ▲  ▲ ▲  ▲ ▲   ▲ 
                 
None   Mild     Moderate    Severe   
Instructions: 
1.  The patient is asked any one of the following questions: 
What number would you give your pain right now? 
What number on a 0 to 10 scale would you give your pain when it is the worst that it 
gets and when it is the best that it gets? 
 
At what number is the pain at an acceptable level for you? 
2. When the explanation suggested in #1 above is not sufficient for the patient, it is 
sometimes helpful to further explain or conceptualize the Numeric Rating Scale in the 
following manner:  
0 = No Pain 
1-3 = Mild Pain (nagging, annoying, interfering little with 
ADLs) 4–6 = Moderate Pain (interferes significantly with 
ADLs) 
7-10 = Severe Pain (disabling; unable to perform ADLs) 
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Appendix x :Faculty clearance 
 
 
Faculty of Health Sciences 
Medical School, 7 York Road, Parktown, 2193 
Fax: (011) 717-2119 
Tel: (011)717-2075/6 
 
 
Reference: Ms Mpumi Mngapu E-
mail: Mpumi.Mngapu@wits.ac.za 
13 February 2013 Person No: 
579277 PAG 
 
Mr A Pramod 
 
P O Box 70519, The Bridge 
Port Elizabeth  
6032  
Eastern Cape South Africa 
 
 
Dear Mr Pramod 
 
Master of Science in Physiotherapy: Approval of Title 
 
We have pleasure in advising that your proposal entitled “A comparison of the presentation 
of patients with cervicogenic headaches and patients with noncervigenic headaches” has 
been approved. Please note that any amendments to this title have to be endorsed by the 
Faculty’s higher degrees committee and formally approved. 
 
Yours sincerely 
 
 
 
 
 
Mrs Sandra Benn 
Faculty Registrar 
Faculty of Health Sciences 
 
 
 
 
 
